Ciclo de Encuentros Directivos
2º Ciclo de Encuentros Directivos Salud – 2021 PROGRAMANOTICIAS (Inaug.)NOTICIAS (Clausura)IMÁGENESSanidad en el punto de mira, ¿avanzamos? Ponencias Julián Isla Linkedin: linkedin.com/in/julianig ; Twitter: @julianig Presidente de Fundación 29 e Ingeniero de Microsoft ¿De verdad utilizamos inteligencia artificial en Medicina o es una falacia del lenguaje? Ver programa Juande Mellado Linkedin: linkedin.com/in/juande-mellado-1a668264 Director General de…
Jornada Cátedra Maimónides
Jornada Cátedra Maimónides #ÉticaMédica 8 de junio: DILEMAS ÉTICOS FRENTE A LA NUEVA LEY DE EUTANASIA 15 de junio: VACUNACIÓN COVID-19: ASPECTOS LEGALES, DEONTOLÓGICOS, ÉTICOS Y ADMINISTRATIVOS 17 de junio: CERTIFICADOS MÉDICOS EN PANDEMIA POR COVID-19: EXIGENCIAS LEGALES, DEONTOLÓGICAS Y ÉTICAS PROGRAMANOTICIAS PRENSAIMAGENES #ÉticaMédica Dirigidas a: Profesionales Médicos Colegiados Organizadas por el Consejo Andaluz de…
Seminarios Violencia de Género
La Redformma es una iniciativa de la Consejería de Salud y Familias de la Junta de Andalucía, desarrollada en colaboración con la EASP, por encomienda de la Dirección General de Salud Pública y Ordenación Farmacéutica de dicha Consejería. Webinarios RED FORMMA – Violencia de Género Seminarios Violencia de Género Coordinación Rocío Antúnez Ganga y Miguel…
Prenatal perfluoroalkyl substance exposure and neuropsychological development throughout childhood: The INMA Project
Background Perfluoroalkyl substances (PFASs) have been related to neurodevelopmental toxicity in animals. However, human studies are inconclusive. Objectives To evaluate the association between prenatal PFAS exposure and neuropsychological development during childhood. Methods 1240 mother–child pairs from the Spanish INMA Project were analyzed. Perfluorohexanesulfonic acid (PFHxS), perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS), and perfluorononanoic acid (PFNA)…
Dietary intake and plasma phospholipid concentrations of saturated, monounsaturated and trans fatty acids and colorectal cancer risk in the EPIC cohort
Epidemiologic studies examining the association between specific fatty acids and colorectal cancer (CRC) risk are inconclusive. We investigated the association between dietary estimates and plasma levels of individual and total saturated (SFA), monounsaturated (MUFA), industrial‐processed trans (iTFA), and ruminant‐sourced trans (rTFA) fatty acids, and CRC risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Baseline fatty acid…
Análisis con perspectiva de género de la Encuesta de Fecundidad 2018 en España
Objetivo Analizar el lenguaje y el contenido del cuestionario utilizado en la Encuesta de Fecundidad 2018 en España, desde una perspectiva de género. Método Diseño cualitativo basado en el análisis de contenido del cuestionario empleado en la Encuesta de Fecundidad 2018, utilizando recomendaciones y guías metodológicas para estadísticas con perspectiva de género y la comparación…
A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study)
Background Patient access to orphan medicinal products (OMPs) is limited and varies between countries, reimbursement decisions on OMPs are complex, and there is a need for more transparent processes to know which criteria should be considered to inform these decisions. This study aimed to determine the most relevant criteria for the reimbursement of OMPs in…
A prospective diet-wide association study for risk of colorectal cancer in EPIC
BACKGROUND & AIMS Evidence regarding the association of dietary exposures with colorectal cancer (CRC) risk is not consistent with a few exceptions. Therefore, we conducted a diet-wide association study (DWAS) in the European Prospective Investigation into Cancer and Nutrition (EPIC) to evaluate the associations between several dietary exposures with CRC risk. METHODS The association of…
Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain
Breast cancer is one of the most frequent malignancies. The aim of the article is to analyse the cost-utility ratio and budgetary impact of talazoparib treatment for patients with locally advanced or metastatic gBRCA + breast cancer from the perspective of the Spanish National Health System. Analyses were based on the EMBRACA clinical trial and the model was constructed…